Cyclic amine base-1 inhibitors having a heterocyclic substituent

Details for Australian Patent Application No. 2004263532 (hide)

Owner Schering Corporation Pharmacopeia Drug Discovery, Inc.

Inventors Guo, Tao; Stamford, Andrew; Cumming, Jared N.; Hobbs, Douglas W.; Wu, Yusheng; Iserloh, Ulrich; Le, Thuy X. H.; Pan, Jianping; Voigt, Johannes H.; Li, Guoqing; Strickland, Corey; Lowrie, Jeffrey F.; Huang, Ying

Agent Griffith Hack

Pub. Number AU-A-2004263532

PCT Pub. Number WO2005/014540

Priority 60/493,646 08.08.03 US

Filing date 4 August 2004

Wipo publication date 17 February 2005

International Classifications

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014540 Priority application(s): WO2005/014540

13 September 2007 Assignment before Grant

  Schering Corporation; Pharmacopeia Drug Discovery, Inc. The application has been assigned to Schering Corporation; Pharmacopeia, Inc.

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263538-Bispecific antibodies for inducing apoptosis of tumor and diseased cells

2004263529-High altitude parachute navigation flight computer